[go: up one dir, main page]

DK0533739T3 - Injicerbart farmaceutisk præparat - Google Patents

Injicerbart farmaceutisk præparat

Info

Publication number
DK0533739T3
DK0533739T3 DK91910762.3T DK91910762T DK0533739T3 DK 0533739 T3 DK0533739 T3 DK 0533739T3 DK 91910762 T DK91910762 T DK 91910762T DK 0533739 T3 DK0533739 T3 DK 0533739T3
Authority
DK
Denmark
Prior art keywords
microspheres
formulations
contain
dia
microns
Prior art date
Application number
DK91910762.3T
Other languages
Danish (da)
English (en)
Inventor
Garza Flores Josue
Soto Laura P Laiseca
Pichardo Jose Guillen
Uribe Juan Angeles
Original Assignee
Aplicaciones Farmaceuticas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmaceuticas filed Critical Aplicaciones Farmaceuticas
Application granted granted Critical
Publication of DK0533739T3 publication Critical patent/DK0533739T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91910762.3T 1990-06-14 1991-06-12 Injicerbart farmaceutisk præparat DK0533739T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.

Publications (1)

Publication Number Publication Date
DK0533739T3 true DK0533739T3 (da) 1995-01-09

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91910762.3T DK0533739T3 (da) 1990-06-14 1991-06-12 Injicerbart farmaceutisk præparat

Country Status (30)

Country Link
US (3) US5360616A (no)
EP (1) EP0533739B1 (no)
JP (1) JP2675675B2 (no)
KR (1) KR0157439B1 (no)
CN (1) CN1057442C (no)
AT (1) ATE109658T1 (no)
AU (1) AU661275B2 (no)
BG (1) BG61179B1 (no)
BR (1) BR9106545A (no)
CA (1) CA2085344C (no)
CZ (1) CZ286793B6 (no)
DE (1) DE69103419T2 (no)
DK (1) DK0533739T3 (no)
ES (1) ES2059142T3 (no)
FI (1) FI107698B (no)
FR (1) FR2663223B1 (no)
HU (1) HUT68709A (no)
IE (1) IE62679B1 (no)
IL (1) IL98459A (no)
NO (1) NO302998B1 (no)
NZ (1) NZ238542A (no)
PL (1) PL167234B1 (no)
PT (1) PT97975B (no)
RU (1) RU2104692C1 (no)
SK (1) SK280564B6 (no)
TN (1) TNSN91048A1 (no)
UA (1) UA27043C2 (no)
UY (1) UY23240A1 (no)
WO (1) WO1991019484A1 (no)
ZA (1) ZA914550B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
JP2002504505A (ja) * 1998-02-25 2002-02-12 アボット・ラボラトリーズ ブトルファノール持続放出性製剤
AU6852900A (en) * 1999-08-20 2001-03-19 Norton Healthcare Ltd Method to produce powders for pulmonary or nasal administration
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
AU2004246870B2 (en) * 2003-06-13 2009-07-23 Skendi Finance Ltd Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
HUE025239T2 (en) 2003-09-03 2016-03-29 Miscon Trading S A Methods for treating endometriosis
US7205281B2 (en) 2003-10-03 2007-04-17 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
SI1675573T2 (sl) 2003-10-23 2012-08-31 Otsuka Pharma Co Ltd Sterilna injektibilna aripiprazolna formulacija z nadzorovanim sproščanjem in postopek
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
CA2667890C (en) 2006-10-31 2015-01-27 Surmodics Pharmaceuticals, Inc. Spheronized polymer particles
ES2661037T3 (es) 2007-07-31 2018-03-27 Otsuka Pharmaceutical Co., Ltd. Procedimientos para producir una suspensión de aripiprazol y una formulación liofilizada
CA2721509A1 (en) * 2008-04-14 2009-10-22 Posi Visionary Solutions Llp Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
BRPI1014362A2 (pt) 2009-04-23 2016-04-05 Pennatek Llc método e composição para sincronizar o tempo de inseminação
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
CN104994865A (zh) 2012-11-28 2015-10-21 杰碧斯联合动物健康第二有限责任公司 用于同步小母猪的授精时间的方法
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
AU2017223595B2 (en) * 2016-02-24 2022-11-24 Eastern Virginia Medical School An improved formulation of long-acting levonorgestrel butanoate injectable depot suspension
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用
CN116036022A (zh) * 2021-12-24 2023-05-02 中国人民解放军军事科学院军事医学研究院 一种新型的含载体材料的药物微球制备及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (no) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (no) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
DE3777721D1 (de) * 1986-08-11 1992-04-30 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
EP0357644B1 (en) * 1987-04-06 1994-08-17 Aberlyn Capital Management Limited Partnership Flash flow fused medicinal implants
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
DE69005800T2 (de) * 1989-05-01 1994-05-19 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres

Also Published As

Publication number Publication date
DE69103419D1 (de) 1994-09-15
US5633014A (en) 1997-05-27
NZ238542A (en) 1993-09-27
US5512303A (en) 1996-04-30
EP0533739B1 (fr) 1994-08-10
JP2675675B2 (ja) 1997-11-12
FR2663223A1 (fr) 1991-12-20
IL98459A0 (en) 1992-07-15
FI107698B (fi) 2001-09-28
NO302998B1 (no) 1998-05-18
UY23240A1 (es) 1991-07-12
FI925661L (fi) 1992-12-11
AU661275B2 (en) 1995-07-20
BR9106545A (pt) 1993-06-01
NO924792D0 (no) 1992-12-11
PL167234B1 (pl) 1995-08-31
BG97166A (bg) 1993-12-24
UA27043C2 (uk) 2000-02-28
TNSN91048A1 (fr) 1992-10-25
ZA914550B (en) 1992-03-25
CS181691A3 (en) 1992-06-17
IL98459A (en) 1996-09-12
HU9203958D0 (en) 1993-03-29
US5360616A (en) 1994-11-01
NO924792L (no) 1993-02-03
RU2104692C1 (ru) 1998-02-20
WO1991019484A1 (fr) 1991-12-26
IE912017A1 (en) 1991-12-18
CN1057961A (zh) 1992-01-22
KR0157439B1 (ko) 1998-11-16
PT97975B (pt) 1998-11-30
PT97975A (pt) 1992-04-30
PL290677A1 (en) 1992-11-30
HUT68709A (en) 1995-07-28
SK280564B6 (sk) 2000-03-13
CN1057442C (zh) 2000-10-18
EP0533739A1 (fr) 1993-03-31
BG61179B1 (bg) 1997-02-28
IE62679B1 (en) 1995-02-22
FI925661A0 (fi) 1992-12-11
CZ286793B6 (cs) 2000-07-12
FR2663223B1 (fr) 1994-12-02
DE69103419T2 (de) 1995-03-30
AU8084791A (en) 1992-01-07
CA2085344C (en) 1998-06-30
ES2059142T3 (es) 1994-11-01
JPH05507694A (ja) 1993-11-04
ATE109658T1 (de) 1994-08-15
CA2085344A1 (en) 1991-12-15

Similar Documents

Publication Publication Date Title
DK0533739T3 (da) Injicerbart farmaceutisk præparat
IL170181A (en) (4r) and (4s)-diastereoisomers of (2s)-2-[oxy-4-propylpyrrolidinyl]butanamide, pharmaceutical compositions comprising them and their use for preparing medicaments
ATE77946T1 (de) Injizierbares langwirkendes mikroteilchenpr|parat zur verabreichung entzuendungshemmender mittel.
HRP20040033B8 (en) Dry powder inhalation system for transpulmonary administration
AU7479796A (en) Preparation of peptide containing biodegradable microspheres by melt process
GEP20032868B (en) Triazolo-Pyridazine Derivatives as Ligands for Gaba Receptors, Methods for Their Production, Pharmaceutical Compositions Containing the Same for Treatment and/or Prevention of disorders of Central Nervous System
DK333884D0 (da) Faste farmaceutiske formuleringer til langsom nulte-ordens frigivelse via kontrolleret overfladeerosion
CA2032068A1 (en) Pharmaceutical lozenges
BR9808331A (pt) Aparelho para quebra de partìculas e separação das partìculas de produto e partìculas residuais e composição de partìculas
CA2339934A1 (en) Medicine for multiple sclerosis
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
CO4900080A1 (es) Microesferas farmaceuticas de acido valproico para administracion oral
IL113178A0 (en) 8 alpha-3-hydroxyestra-1,3,5(11) tetraen-17-one (delta9(11)-dehydro-8 isoestrone its preparation andpharmaceutical composition containing it and its use
JP2001524513A5 (no)
DK0482183T3 (da) Histamin-H3-receptoragonistforbindelser til terapeutisk anvendelse, farmaceutiske sammensætninger virkende som agonister for nævnte receptor og fremstillingsmetode
EP0397044A3 (de) Neue Arylsulfonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
MA26437A1 (fr) Derives de trans-piperazine-1-yl-spiro (cyclohexane-1,1'-isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant.
AU8337391A (en) Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation
YU57695A (sh) (r)-enantiomer derivata dihidro-2,3-benzodiazepina
CA2110041A1 (en) Method of producing reproducible particles
BE901254A (fr) Formulations pharmaceutiques et veterinaires.
BR9611407A (pt) Derivados de 1-arilsulfonila, aril(tio)carbonil-piridazino e métodos de preparação.
SV1998000062A (es) Formulaciones farmaceuticas y otras ref. jab 865